SEC Form 4 · accession 0001225208-19-004218
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian C Read
Officer — Executive Chairman · Director
Period of report
Feb 27, 2019
Accepted (ET)
Mar 1, 2019 · 7:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000078003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2019 | A | 347,327 | $0.00 | A | 1,934,064 | D | |
| Common StockF2 | Feb 27, 2019 | F | 90,352 | $42.93 | D | 1,843,712 | D | |
| Common StockF3 | Feb 27, 2019 | F | 153,644 | $42.93 | D | 1,690,068 | D | |
| Common Stock | holding | — | — | — | 11,442 | I | By Rule 16b-3 Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF4 | $43.35 | Feb 28, 2019 | A | 240,670 | A | Feb 28, 2024 | Feb 28, 2024 | Common Stock | 240,670 | 240,670 | D |
| Stock Appreciation RightsF5 | $43.35 | Feb 28, 2019 | A | 202,819 | A | Feb 28, 2026 | Feb 28, 2026 | Common Stock | 202,819 | 202,819 | D |
Explanation of responses
- F1The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
- F2The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).
- F3The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
- F4The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
- F5The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.